Your browser doesn't support javascript.
loading
Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration.
Onuma, Kazuhiro; Watanabe, Kenji; Isayama, Keishiro; Ogi, Sayaka; Tokunaga, Yasunori; Mizukami, Yoichi.
Afiliação
  • Onuma K; Institute of Gene Research, Yamaguchi University Science Research Center, Yamaguchi, Japan.
  • Watanabe K; Pharmaceutical Research Laboratory, Pharmaceutical Division, UBE Corporation, Yamaguchi, Japan.
  • Isayama K; Institute of Gene Research, Yamaguchi University Science Research Center, Yamaguchi, Japan.
  • Ogi S; Institute of Gene Research, Yamaguchi University Science Research Center, Yamaguchi, Japan.
  • Tokunaga Y; Pharmaceutical Research Laboratory, Pharmaceutical Division, UBE Corporation, Yamaguchi, Japan.
  • Mizukami Y; Pharmaceutical Research Laboratory, Pharmaceutical Division, UBE Corporation, Yamaguchi, Japan.
Br J Pharmacol ; 181(15): 2545-2565, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38599607
ABSTRACT
BACKGROUND AND

PURPOSE:

Bardoxolone methyl (2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester, CDDO-Me) is a potent activator of nuclear factor erythroid 2-related factor 2 (Nrf2), which induces the expression of antioxidative-associated genes. CDDO-Me exerts protective effects against chronic inflammatory diseases in the kidneys and lungs. However, its pharmacological effects on metabolic dysfunction-associated steatohepatitis (MASH) caused by fat accumulation remain unknown. In this study, we examined the hepatoprotective effects of CDDO-Me in a diet-induced MASH mouse model and elucidated its pharmacological mechanisms using RNA-seq analysis. EXPERIMENTAL

APPROACH:

CDDO-Me was orally administered to mice fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD), and histological, biochemical, and transcriptomic analyses were performed on livers of mice that developed MASH. KEY

RESULTS:

CDDO-Me administration induced the expression of antioxidant genes and cholesterol transporters downstream of Nrf2 and significantly prevented the symptoms of MASH. Whole-transcriptome analysis revealed that CDDO-Me inhibited the inflammatory pathway that led to phagocyte recruitment, in addition to activating the Nrf2-dependent pathway. Among inflammatory pathways, CC chemokine ligands (CCL)3 and CCL4, which are downstream of NF-κB and are associated with the recruitment of macrophages expressing CC chemokine receptors (CCR)1 and CCR5, were released into the blood in MASH mice. However, CDDO-Me directly inhibited the expression of CCL3-CCR1 and CCL4-CCR5 in macrophages. CONCLUSIONS AND IMPLICATIONS Overall, we revealed the potent hepatoprotective effect of CDDO-Me in a MASH mouse model and demonstrated that its pharmacological effects were closely associated with a reduction of macrophage infiltration, through CCL3-CCR1 and CCL4-CCR5 inhibition, in addition to Nrf2-mediated hepatoprotective effects.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oleanólico / Dieta Hiperlipídica / Macrófagos / Camundongos Endogâmicos C57BL Limite: Animals Idioma: En Revista: Br J Pharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oleanólico / Dieta Hiperlipídica / Macrófagos / Camundongos Endogâmicos C57BL Limite: Animals Idioma: En Revista: Br J Pharmacol Ano de publicação: 2024 Tipo de documento: Article